Rapid Micro Biosystems Inc (RPID)
0.935
-0.05
(-4.98%)
USD |
NASDAQ |
May 01, 16:00
0.935
0.00 (0.00%)
After-Hours: 17:50
Rapid Micro Biosystems Cash from Financing (TTM): 0.149M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.149M |
September 30, 2023 | 0.248M |
June 30, 2023 | 0.351M |
March 31, 2023 | 0.352M |
December 31, 2022 | 0.693M |
September 30, 2022 | -0.65M |
June 30, 2022 | 138.51M |
Date | Value |
---|---|
March 31, 2022 | 137.14M |
December 31, 2021 | 216.74M |
September 30, 2021 | 218.05M |
June 30, 2021 | 78.75M |
March 31, 2021 | 134.80M |
December 31, 2020 | 64.23M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.65M
Minimum
Sep 2022
218.05M
Maximum
Sep 2021
76.11M
Average
64.23M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
Ainos Inc | 4.924M |
OpGen Inc | 7.287M |
Zomedica Corp | -- |
LENSAR Inc | -- |
Eargo Inc (DELISTED) | 33.86M |